PET Scan 18 F-Fluorodeoxyglucose Uptake and Prognosis in Patients With Resected Clinical Stage IA Non-small Cell Lung Cancer

This publication has 26 references indexed in Scilit:

• Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
  Journal of Clinical Oncology, 2008
• Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
  Journal of Clinical Oncology, 2008
• Prognostic value of FDG uptake in early stage non-small cell lung cancer☆
  European Journal of Cardio-Thoracic Surgery, 2008
• Survival after Surgery in Stage IA and IB Non–Small Cell Lung Cancer
  American Journal of Respiratory and Critical Care Medicine, 2008
• Cancer Statistics, 2008
  CA: A Cancer Journal for Clinicians, 2008
• A Comparison of the Diagnostic Accuracy of¹⁸F-FDG PET and CT in the Characterization of Solitary Pulmonary Nodules
  Journal of Nuclear Medicine, 2008
• Prognostic factors for survival of stage I nonsmall cell lung cancer patients
  Cancer, 2007
• Prognostic significance of [¹⁸F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma
  Cancer, 2006
• The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival
  The Journal of Thoracic and Cardiovascular Surgery, 2005
• Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1
  European Journal of Cardio-Thoracic Surgery, 2004